<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Metab Insights</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Metab Insights</journal-id><journal-title-group><journal-title>Nutrition and Metabolic Insights</journal-title></journal-title-group><issn pub-type="epub">1178-6388</issn><publisher><publisher-name>Libertas Academica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23946663</article-id><article-id pub-id-type="pmc">3738453</article-id><article-id pub-id-type="doi">10.4137/NMI.S8299</article-id><article-id pub-id-type="publisher-id">nmi-4-2011-065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Effects of Acute Caffeinated Coffee Consumption on Energy Utilization Related to Glucose and Lipid Oxidation from Short Submaximal Treadmill Exercise in Sedentary Men</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Leelarungrayub</surname><given-names>Donrawee</given-names></name><xref ref-type="corresp" rid="c1-nmi-4-2011-065"></xref><xref ref-type="aff" rid="af1-nmi-4-2011-065"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sallepan</surname><given-names>Maliwan</given-names></name><xref ref-type="aff" rid="af2-nmi-4-2011-065"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Charoenwattana</surname><given-names>Sukanya</given-names></name><xref ref-type="aff" rid="af2-nmi-4-2011-065"><sup>2</sup></xref></contrib></contrib-group><aff id="af1-nmi-4-2011-065"><label>1</label>Oxidative Stress, Nutrition and Exercise Biochemistry Laboratory, Department of Physical Therapy, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.</aff><aff id="af2-nmi-4-2011-065"><label>2</label>College of Sport Sciences, Burapha University, Bangsean, Chonburi 20131, Thailand.</aff><author-notes><corresp id="c1-nmi-4-2011-065">Corresponding author email: <email>nuttakan@chiangmai.ac.th</email></corresp></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2011</year></pub-date><volume>4</volume><fpage>65</fpage><lpage>72</lpage><permissions><copyright-statement>© the author(s), publisher and licensee Libertas Academica Ltd.</copyright-statement><copyright-year>2011</copyright-year><license><license-p>This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="2823" xml_f="2833" txt_i="11" txt_f="21">Objective:</offsets></title><p><offsets xml_i="2844" xml_f="2958" txt_i="22" txt_f="136">Aim of this study was to evaluate the short term effect of coffee drinking on energy utilization in sedentary men.</offsets></p></sec><sec><title><offsets xml_i="2980" xml_f="2988" txt_i="138" txt_f="146">Methods:</offsets></title><p><offsets xml_i="2999" xml_f="3505" txt_i="147" txt_f="653">This study was performed in healthy sedentary men, who were randomized into three groups, control (n = 6), decaffeinated (n = 10), and caffeine (n = 10). The caffeine dose in coffee was rechecked and calculated for individual volunteers at 5 mg/kg. Baseline before drinking, complete blood count (CBC), glucose, antioxidant capacity, lipid peroxide, and caffeine in blood was evaluated. After drinking coffee for 1 hr, the submaximal exercise test with a modified Bruce protocol was carried out, and the VO</offsets><sub><offsets xml_i="3510" xml_f="3511" txt_i="653" txt_f="654">2</offsets></sub><offsets xml_i="3517" xml_f="3616" txt_i="654" txt_f="753"> and RER were analyzed individually at 80% maximal heart rate, then the blood was repeat evaluated.</offsets></p></sec><sec><title><offsets xml_i="3638" xml_f="3646" txt_i="755" txt_f="763">Results:</offsets></title><p><offsets xml_i="3657" xml_f="3824" txt_i="764" txt_f="931">Three groups showed a nonsignificant difference in CBC results and physical characteristics. The caffeine group showed significant changes in all parameters; higher VO</offsets><sub><offsets xml_i="3829" xml_f="3830" txt_i="931" txt_f="932">2</offsets></sub><offsets xml_i="3836" xml_f="3846" txt_i="932" txt_f="942"> levels, (</offsets><italic><offsets xml_i="3854" xml_f="3855" txt_i="942" txt_f="943">P</offsets></italic><offsets xml_i="3864" xml_f="3889" txt_i="943" txt_f="968"> = 0.037) and lower RER (</offsets><italic><offsets xml_i="3897" xml_f="3898" txt_i="968" txt_f="969">P</offsets></italic><offsets xml_i="3907" xml_f="4025" txt_i="969" txt_f="1087"> = 0.047), when compared to the baseline. Furthermore, the glucose level after exercise test increased significantly (</offsets><italic><offsets xml_i="4033" xml_f="4034" txt_i="1087" txt_f="1088">P</offsets></italic><offsets xml_i="4043" xml_f="4087" txt_i="1088" txt_f="1132"> = 0.033) as well as lipid peroxide levels (</offsets><italic><offsets xml_i="4095" xml_f="4096" txt_i="1132" txt_f="1133">P</offsets></italic><offsets xml_i="4105" xml_f="4175" txt_i="1133" txt_f="1203"> = 0.005), whereas antioxidant capacity did not change significantly (</offsets><italic><offsets xml_i="4183" xml_f="4184" txt_i="1203" txt_f="1204">P</offsets></italic><offsets xml_i="4193" xml_f="4331" txt_i="1204" txt_f="1342"> = 0.759), when compared to the before exercise testing. In addition, the blood caffeine level also increased only in the caffeine group (</offsets><italic><offsets xml_i="4339" xml_f="4340" txt_i="1342" txt_f="1343">P</offsets></italic><offsets xml_i="4349" xml_f="4359" txt_i="1343" txt_f="1353"> = 0.008).</offsets></p></sec><sec><title><offsets xml_i="4381" xml_f="4392" txt_i="1355" txt_f="1366">Conclusion:</offsets></title><p><offsets xml_i="4403" xml_f="4548" txt_i="1367" txt_f="1512">Short consumption of caffeinated coffee (5 mg/kg of caffeine), improves energy utilization and relates to glucose derivation and lipid oxidation.</offsets></p></sec></abstract><kwd-group><kwd>caffeine</kwd><kwd>glucose</kwd><kwd>lipid</kwd><kwd>VO<sub>2</sub></kwd><kwd>RER</kwd><kwd>antioxidant</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="4747" xml_f="4757" txt_i="1521" txt_f="1531">Background</offsets></title><p><offsets xml_i="4768" xml_f="4942" txt_i="1532" txt_f="1706">At present, caffeine is a widely used compound in general population and athletics with ergogenic and alertness effects, which is not currently considered a doping substance.</offsets><xref ref-type="bibr" rid="b1-nmi-4-2011-065"><offsets xml_i="4988" xml_f="4989" txt_i="1706" txt_f="1707">1</offsets></xref><offsets xml_i="4996" xml_f="5109" txt_i="1707" txt_f="1820"> Caffeine is contained in various foods and drinks, such as coffee, tea, cola, chocolate, and some energy drinks.</offsets><xref ref-type="bibr" rid="b1-nmi-4-2011-065"><offsets xml_i="5155" xml_f="5156" txt_i="1820" txt_f="1821">1</offsets></xref><offsets xml_i="5163" xml_f="5164" txt_i="1821" txt_f="1822">,</offsets><xref ref-type="bibr" rid="b2-nmi-4-2011-065"><offsets xml_i="5210" xml_f="5211" txt_i="1822" txt_f="1823">2</offsets></xref><offsets xml_i="5218" xml_f="5428" txt_i="1823" txt_f="2033"> Previous evidence has shown that absorbance of caffeine in plasma gives a maximal peak of between 30–90 min after supplementation and a half-life of 5 h before excretion through urine as free caffeine (1%–3%).</offsets><xref ref-type="bibr" rid="b3-nmi-4-2011-065"><offsets xml_i="5474" xml_f="5475" txt_i="2033" txt_f="2034">3</offsets></xref><offsets xml_i="5482" xml_f="5627" txt_i="2034" txt_f="2179"> Caffeine has an ergogenic effect stimulates lypolysis to release free fatty acid through inhibiting phosphodiesterease and enhancing cyclic AMP.</offsets><xref ref-type="bibr" rid="b4-nmi-4-2011-065"><offsets xml_i="5673" xml_f="5674" txt_i="2179" txt_f="2180">4</offsets></xref><offsets xml_i="5681" xml_f="5743" txt_i="2180" txt_f="2242"> Furthermore, it spares the body’s limited carbohydrate store.</offsets><xref ref-type="bibr" rid="b5-nmi-4-2011-065"><offsets xml_i="5789" xml_f="5790" txt_i="2242" txt_f="2243">5</offsets></xref><offsets xml_i="5797" xml_f="5992" txt_i="2243" txt_f="2438"> Thus, it can be concluded that caffeine mobilizes free fatty acids from adipose tissue to the muscle, which activates the energy production system, and spare glycogen also extends exercise time.</offsets><xref ref-type="bibr" rid="b5-nmi-4-2011-065"><offsets xml_i="6038" xml_f="6039" txt_i="2438" txt_f="2439">5</offsets></xref><offsets xml_i="6046" xml_f="6142" txt_i="2439" txt_f="2535"> Many studies have shown the benefits of caffeine on increased physical performance in athletes,</offsets><xref ref-type="bibr" rid="b6-nmi-4-2011-065"><offsets xml_i="6188" xml_f="6189" txt_i="2535" txt_f="2536">6</offsets></xref><offsets xml_i="6196" xml_f="6197" txt_i="2536" txt_f="2537">–</offsets><xref ref-type="bibr" rid="b8-nmi-4-2011-065"><offsets xml_i="6243" xml_f="6244" txt_i="2537" txt_f="2538">8</offsets></xref><offsets xml_i="6251" xml_f="6445" txt_i="2538" txt_f="2732"> for example, its activity on the ergogenic effect acts directly on skeletal muscle and important parts of the brain or spinal cord, which may enhance good performance during endurance exercise.</offsets><xref ref-type="bibr" rid="b6-nmi-4-2011-065"><offsets xml_i="6491" xml_f="6492" txt_i="2732" txt_f="2733">6</offsets></xref><offsets xml_i="6499" xml_f="6639" txt_i="2733" txt_f="2873"> Laurent’s study showed that supplementation at 6 mg/kg of caffeine increased plasma beta-endorphin following two hours of cycling at 65% VO</offsets><sub><offsets xml_i="6644" xml_f="6645" txt_i="2873" txt_f="2874">2</offsets></sub><offsets xml_i="6651" xml_f="6657" txt_i="2874" txt_f="2880"> peak.</offsets><xref ref-type="bibr" rid="b7-nmi-4-2011-065"><offsets xml_i="6703" xml_f="6704" txt_i="2880" txt_f="2881">7</offsets></xref><offsets xml_i="6711" xml_f="6931" txt_i="2881" txt_f="3101"> Previous study has shown that acute supplementation of caffeine at 5 mg/kg of body weight, in runners (aged; 25.4 ± 6.9 yr) in a hot and humid climate, helped significantly to increase running time to exhaustion, but VO</offsets><sub><offsets xml_i="6936" xml_f="6940" txt_i="3101" txt_f="3105">2max</offsets></sub><offsets xml_i="6946" xml_f="7035" txt_i="3105" txt_f="3194">, heart rate, core body temperature, and rate of perceived exertion (RPE) did not change.</offsets><xref ref-type="bibr" rid="b8-nmi-4-2011-065"><offsets xml_i="7081" xml_f="7082" txt_i="3194" txt_f="3195">8</offsets></xref><offsets xml_i="7089" xml_f="7131" txt_i="3195" txt_f="3237"> Updated evidence by Franco and colleague </offsets><xref ref-type="bibr" rid="b9-nmi-4-2011-065"><offsets xml_i="7177" xml_f="7178" txt_i="3237" txt_f="3238">9</offsets></xref><offsets xml_i="7185" xml_f="7506" txt_i="3238" txt_f="3556"> showed that caffeine supplementation at 5 mg/kg of body weight for 7 days reduced the percentage of fat, when compared to creatine supplementation rates. It is suggested also that low to high doses of caffeine (approximately 3–6 mg/kg) enhance the performance in trained athletes, but a high dose (&gt;9 mg/kg) does not.</offsets><xref ref-type="bibr" rid="b10-nmi-4-2011-065"><offsets xml_i="7553" xml_f="7555" txt_i="3556" txt_f="3558">10</offsets></xref><offsets xml_i="7562" xml_f="7660" txt_i="3558" txt_f="3656"> In addition, caffeine is claimed to be an antioxidant agent by inhibiting LDL oxidation in vitro,</offsets><xref ref-type="bibr" rid="b11-nmi-4-2011-065"><offsets xml_i="7707" xml_f="7709" txt_i="3656" txt_f="3658">11</offsets></xref><offsets xml_i="7716" xml_f="7717" txt_i="3658" txt_f="3659">,</offsets><xref ref-type="bibr" rid="b12-nmi-4-2011-065"><offsets xml_i="7764" xml_f="7766" txt_i="3659" txt_f="3661">12</offsets></xref><offsets xml_i="7773" xml_f="8195" txt_i="3661" txt_f="4083"> but no evidence shows this activity in humans. In this study, experimental design was set up with a short time after supplement of caffeine at 5 mg/kg of body weight for 1 hr and comparing the changing of energy utilization, glucose release antioxidant status, and lipid oxidation before and after exercise test because of its maximal dose is absorbed in plasma in approximately 30–90 min, and the half-life is about 5 h.</offsets><xref ref-type="bibr" rid="b13-nmi-4-2011-065"><offsets xml_i="8242" xml_f="8244" txt_i="4083" txt_f="4085">13</offsets></xref></p></sec><sec sec-type="methods"><title><offsets xml_i="8292" xml_f="8299" txt_i="4087" txt_f="4094">Methods</offsets></title><p><offsets xml_i="8310" xml_f="8832" txt_i="4095" txt_f="4617">All programs were approved by the Human Ethics Committee (Declaration of Helsinki) (2001) at the Faculty of Associated Medical Sciences, Chiang Mai University, Thailand. All volunteers were 20–24 years old, and non-smoking and non-athletic healthy males. Individual health status was interviewed for some illness, such as hospital admitted, drug administrated, or medical treated, and must not took any drugs, or nutrient supplements for 6 months before. Their body mass index (BMI) was within normal range (18.5–24.9 kg/m</offsets><sup><offsets xml_i="8837" xml_f="8838" txt_i="4617" txt_f="4618">2</offsets></sup><offsets xml_i="8844" xml_f="9045" txt_i="4618" txt_f="4819">), according to the WHO and International Obesity Task Force. All subjects were selected by simple randomized sampling into three groups; Caffeine (n = 10), Decaffeinated (n = 10), and Control (n = 6).</offsets></p></sec><sec><title><offsets xml_i="9067" xml_f="9081" txt_i="4821" txt_f="4835">Protocol Study</offsets></title><p><offsets xml_i="9092" xml_f="9542" txt_i="4836" txt_f="5286">Body weight was evaluated in order to calculate the level of caffeine supplementation. Caffeine in coffee powder(MOCCONAINSTANT, Expressor, Thailand) was measured accurately by high performance chromatography (HPLC) by comparison to the standard caffeine (Sigma St. Louis, USA). On the day of experiment, all volunteers could not consume coffee for at least 1.5 h before the blood sample was taken and the protocol could start. Energy utilization; VO</offsets><sub><offsets xml_i="9547" xml_f="9548" txt_i="5286" txt_f="5287">2</offsets></sub><offsets xml_i="9554" xml_f="10063" txt_i="5287" txt_f="5796"> and RER at 80% maximal heart rate (MHR), was evaluated twice; the first test for baseline and the second for supplemented caffeinated coffee, decaffeinated coffee (Instant freeze dried decaffeinated coffee; Expressor, Thailand) or no supplement (control). For biochemistry laboratories, glucose, lipid oxidation, caffeine, and total antioxidant capacity were analyzed before and after supplementation. Caffeine in coffee was supplemented at 5 mg/kg of body weight in each subject of the caffeinated group. VO</offsets><sub><offsets xml_i="10068" xml_f="10069" txt_i="5796" txt_f="5797">2</offsets></sub><offsets xml_i="10075" xml_f="10164" txt_i="5797" txt_f="5886"> and RER were analyzed by gas analysis using the Gas-analysis Breath-by-Breath Technique.</offsets></p></sec><sec><title><offsets xml_i="10186" xml_f="10216" txt_i="5888" txt_f="5918">Energy Utilization Measurement</offsets></title><p><offsets xml_i="10227" xml_f="10256" txt_i="5919" txt_f="5948">Direct oxygen consumption (VO</offsets><sub><offsets xml_i="10261" xml_f="10262" txt_i="5948" txt_f="5949">2</offsets></sub><offsets xml_i="10268" xml_f="10394" txt_i="5949" txt_f="6075">) and respiratory exchange ratio (RER) were parameters analyzed automatically with a CPX Ultima Gax exchange from Med-Graphics</offsets><sup><offsets xml_i="10399" xml_f="10400" txt_i="6075" txt_f="6076">®</offsets></sup><offsets xml_i="10406" xml_f="10810" txt_i="6076" txt_f="6480"> (St. Paul, Minnesota, USA). Subjects were asked to wear a mouthpiece held with a mask connected to a pneumatic sensor that could detect bi-directional differential pressure, and the heart rate was monitored at the middle finger. Each breath passing through the system was controlled with a nose clip. Submaximal treadmill exercise with a modified Bruce protocol was started automatically using GE’s CASE</offsets><sup><offsets xml_i="10815" xml_f="10816" txt_i="6480" txt_f="6481">®</offsets></sup><offsets xml_i="10822" xml_f="11026" txt_i="6481" txt_f="6685"> Exercise Testing System (USA). Warm up started with running on the treadmill at 0.8 mph, on a 0% slope for 2 min, and the program progressed every three minutes with changing speed and slope. Directed VO</offsets><sub><offsets xml_i="11031" xml_f="11032" txt_i="6685" txt_f="6686">2</offsets></sub><offsets xml_i="11038" xml_f="11177" txt_i="6686" txt_f="6825"> and RER were analysed automatically by the Breeze-Suit Software program. When the heart rate was 80% MHR, exercise was stopped, and the VO</offsets><sub><offsets xml_i="11182" xml_f="11183" txt_i="6825" txt_f="6826">2</offsets></sub><offsets xml_i="11189" xml_f="11418" txt_i="6826" txt_f="7055"> (mL/kg/min) and RER results were shown after calm down by walking on the treadmill for 3 minutes. The criteria, precautions, and time to stop exercise followed the guideline of the American College of Sport Medicine (ACSM 2004),</offsets><xref ref-type="bibr" rid="b14-nmi-4-2011-065"><offsets xml_i="11465" xml_f="11467" txt_i="7055" txt_f="7057">14</offsets></xref><offsets xml_i="11474" xml_f="11682" txt_i="7057" txt_f="7265"> for example; target heart rate at 80% MHR, complaint of strong dyspnea (Borge Scale) or physical signs such as muscle pain, cramp, headaches, heart palpitations, heartburn, blurred vision, or severe dyspnea.</offsets></p></sec><sec><title><offsets xml_i="11704" xml_f="11726" txt_i="7267" txt_f="7289">Biochemical Parameters</offsets></title><p><offsets xml_i="11737" xml_f="11831" txt_i="7290" txt_f="7384">Lipid peroxidation was measured by the TBARs method, which followed Leelarungrayub’s protocol.</offsets><xref ref-type="bibr" rid="b15-nmi-4-2011-065"><offsets xml_i="11878" xml_f="11880" txt_i="7384" txt_f="7386">15</offsets></xref><offsets xml_i="11887" xml_f="12435" txt_i="7386" txt_f="7934"> Two hundred and fifty microliters of plasma were mixed with 750 μl of ortho-phosphoricacid (2.5%,v:v) and vortexed. Then, 500 μl of Thiobarbituric acid (TBA) (0.2 mol/L) in Tris solution (0.14 mol/L) was added. After incubation in a water bath (90 °C) for 30 min, all samples were cooled and centrifuged at 10,000 rpm for 3 min. A clear pink color of supernatant was read with a spectrophotometer at 532 nm. The yield of MDA in the sample was calculated by comparing with the absorbance of standard Tetramethoxypropane (TMP) (Sigma) (0–50 μmol/L).</offsets></p><p><offsets xml_i="12442" xml_f="12543" txt_i="7935" txt_f="8036">Total antioxidant capacity (TAC) of fresh plasma was assayed with ABTs cation radical decolorization.</offsets><xref ref-type="bibr" rid="b16-nmi-4-2011-065"><offsets xml_i="12590" xml_f="12592" txt_i="8036" txt_f="8038">16</offsets></xref><offsets xml_i="12599" xml_f="13272" txt_i="8038" txt_f="8711"> Stock ABTs cation radical was produced by mixing ABTs (14 mmol/L) and potassium persulfate (14 mmol/L) together, and leaving in the dark overnight. Working ABTs cation radical was diluted in de-ionized water until absorbance was shown between 0.68 and 0.74 at 734 nm, before adding plasma. Ten μl of plasma were added to 990 μl of working ABTs cation radical and gently alternated inversely by shaking nine times before adding in the spectrophotometer. Decreased absorbance was recorded continuously every minute for three minutes and finally calculated to ΔA/min. The TAC of the plasma was calculated by comparing with the ΔA/min of standard Trolox (Sigma) (0–10 mmol/L).</offsets></p><p><offsets xml_i="13279" xml_f="13418" txt_i="8712" txt_f="8851">Glucose was analyzed with a commercial chemical kit at the Clinical Medical Technology Central Laboratory, Chiang Mai University, Thailand.</offsets></p><p><offsets xml_i="13425" xml_f="13479" txt_i="8852" txt_f="8906">Caffeine in coffee and plasma were analyzed with HPLC.</offsets><xref ref-type="bibr" rid="b17-nmi-4-2011-065"><offsets xml_i="13526" xml_f="13528" txt_i="8906" txt_f="8908">17</offsets></xref><offsets xml_i="13535" xml_f="13607" txt_i="8908" txt_f="8980"> Each 200 μl plasma sample was added to 200 μl of 0.8 M perchloric acid.</offsets><xref ref-type="bibr" rid="b18-nmi-4-2011-065"><offsets xml_i="13654" xml_f="13656" txt_i="8980" txt_f="8982">18</offsets></xref><offsets xml_i="13663" xml_f="14096" txt_i="8982" txt_f="9415"> The mixed solution was vortexed for 10 s and centrifuged at 6,000 rpm for 5 min. The 20 μl of supernatant was injected into the chromatrographic system and the peak height was identified with a Phenomenex C18 analytical column (Waters Milipore Inc, Milford. MA) (1.5 cm × 4.6 mm) together with a C18 guard column. An isocratic mobile phase was run, with a mixed solution of methanol (HPLC grade, Labscan, Thailand) and water (70:30 </offsets><italic><offsets xml_i="14104" xml_f="14107" txt_i="9415" txt_f="9418">v/v</offsets></italic><offsets xml_i="14116" xml_f="14217" txt_i="9418" txt_f="9519">), and a flow rate set at 1 ml/min. The specific retention time of caffeine was identified at 254 nm.</offsets></p></sec><sec><title><offsets xml_i="14239" xml_f="14257" txt_i="9521" txt_f="9539">Statistic Analysis</offsets></title><p><offsets xml_i="14268" xml_f="14341" txt_i="9540" txt_f="9613">Normal distribution of glucose, anti-oxidant capacity, lipid peroxide, VO</offsets><sub><offsets xml_i="14346" xml_f="14347" txt_i="9613" txt_f="9614">2</offsets></sub><offsets xml_i="14353" xml_f="14843" txt_i="9614" txt_f="10104">, RER, and caffeine levels in the blood was tested with a Kolmogorov-Smirnov test. One-way ANOVA was statistical analyzed between three groups either before or after the submaximal treadmill exercise test, and a Least Significant Difference (LSD) was used for comparisons within the groups. All data between pre- and post-consumption of coffee were analyzed by an non-parametric paired t-test (Wilcoxon Sign Rank Test) in an SPSS program (Version 10). Raw data represented the mean ± SD. A </offsets><italic><offsets xml_i="14851" xml_f="14852" txt_i="10104" txt_f="10105">P</offsets></italic><offsets xml_i="14861" xml_f="14899" txt_i="10105" txt_f="10140"> &lt; 0.05 was considered significant.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="14940" xml_f="14947" txt_i="10142" txt_f="10149">Results</offsets></title><p><offsets xml_i="14958" xml_f="15007" txt_i="10150" txt_f="10199">Characteristics of the subjects are presented in </offsets><xref ref-type="table" rid="t1-nmi-4-2011-065"><offsets xml_i="15054" xml_f="15061" txt_i="10199" txt_f="10206">Table 1</offsets></xref><offsets xml_i="15068" xml_f="15278" txt_i="10206" txt_f="10416">, in which there is no statistical difference between age, weight, height, or body mass index (BMI). In the control, decaffeinated, and caffeine group, the CBC results showed values within the reference ranges.</offsets></p><p><offsets xml_i="15285" xml_f="15603" txt_i="10417" txt_f="10735">From the HPLC evaluation the caffeine in Moccona caffeinated instance coffee, the standard caffeine showed a specific peak and retention time at 3.52 ± 0.11 min and the results showed the yield of caffeine in coffee at one gram was 167.8 ± 1.25 milligram, whereas no caffeine peak showed from the decaffeinated coffee.</offsets></p><p><offsets xml_i="15610" xml_f="15849" txt_i="10736" txt_f="10975">From the results all data either before or after exercist test showed normal distribution, then comparison between three groups with one-way ANOVA and LSD had been followed. In this study, energy utilization was determined with directed VO</offsets><sub><offsets xml_i="15854" xml_f="15855" txt_i="10975" txt_f="10976">2</offsets></sub><offsets xml_i="15861" xml_f="15988" txt_i="10976" txt_f="11103"> (mL/kg/min) at heart rate was 80% MHR from a Breath-by-Breath analysis following the modified Bruce protocol on treadmill. In </offsets><xref ref-type="table" rid="t2-nmi-4-2011-065"><offsets xml_i="16035" xml_f="16042" txt_i="11103" txt_f="11110">Table 2</offsets></xref><offsets xml_i="16049" xml_f="16130" txt_i="11110" txt_f="11191">, baseline or the first test of all groups showed no significant difference in VO</offsets><sub><offsets xml_i="16135" xml_f="16136" txt_i="11191" txt_f="11192">2</offsets></sub><offsets xml_i="16142" xml_f="16477" txt_i="11192" txt_f="11527">, except in the decaffeinated group (control = 27.3 ± 1.89, decaffeinated = 32.52 ± 5.19, and caffeine = 28.07 ± 4.45 mL/kg/min), which also differed in the second test (control = 29.68 ± 3.90, decaffeinated = 34.51 ± 6.34, and caffeine = 32.41 ± 5.17 mL/kg/min). When comparing between the first and second tests in each group, the VO</offsets><sub><offsets xml_i="16482" xml_f="16483" txt_i="11527" txt_f="11528">2</offsets></sub><offsets xml_i="16489" xml_f="16612" txt_i="11528" txt_f="11651"> level increased (32.41 ± 5.17 mL/kg/min) significantly from baseline (28.07 ± 4.45 mL/kg/min) in only the caffeine group (</offsets><italic><offsets xml_i="16620" xml_f="16621" txt_i="11651" txt_f="11652">P</offsets></italic><offsets xml_i="16630" xml_f="16701" txt_i="11652" txt_f="11723"> = 0.037). Whereas, no statistical difference was seen in the control (</offsets><italic><offsets xml_i="16709" xml_f="16710" txt_i="11723" txt_f="11724">P</offsets></italic><offsets xml_i="16719" xml_f="16753" txt_i="11724" txt_f="11758"> = 0.115) or decaffeinated group (</offsets><italic><offsets xml_i="16761" xml_f="16762" txt_i="11758" txt_f="11759">P</offsets></italic><offsets xml_i="16771" xml_f="16781" txt_i="11759" txt_f="11769"> = 0.214).</offsets></p><p><offsets xml_i="16788" xml_f="16837" txt_i="11770" txt_f="11819">The respiratory exchange ratio (RER) is shown in </offsets><xref ref-type="table" rid="t2-nmi-4-2011-065"><offsets xml_i="16884" xml_f="16891" txt_i="11819" txt_f="11826">Table 2</offsets></xref><offsets xml_i="16898" xml_f="17033" txt_i="11826" txt_f="11961">. There was no statistical difference either in the first (control = 1.09 ± 0.07, decaffeinated = 1.07 ± 0.10, caffeine = 1.06 ± 0.08, </offsets><italic><offsets xml_i="17041" xml_f="17042" txt_i="11961" txt_f="11962">P</offsets></italic><offsets xml_i="17051" xml_f="17157" txt_i="11962" txt_f="12068"> = 0.758) or the second test (control = 1.03 ± 0.06, decaffeinated = 1.02 ± 0.05, caffeine = 0.99 ± 0.06, </offsets><italic><offsets xml_i="17165" xml_f="17166" txt_i="12068" txt_f="12069">P</offsets></italic><offsets xml_i="17175" xml_f="17294" txt_i="12069" txt_f="12188"> = 0.464). However, while a statistical difference was found between the first and second tests of the caffeine group (</offsets><italic><offsets xml_i="17302" xml_f="17303" txt_i="12188" txt_f="12189">P</offsets></italic><offsets xml_i="17312" xml_f="17372" txt_i="12189" txt_f="12249"> = 0.047), a paired t-test showed no change in the control (</offsets><italic><offsets xml_i="17380" xml_f="17381" txt_i="12249" txt_f="12250">P</offsets></italic><offsets xml_i="17390" xml_f="17418" txt_i="12250" txt_f="12278"> = 0.077) or decaffeinated (</offsets><italic><offsets xml_i="17426" xml_f="17427" txt_i="12278" txt_f="12279">P</offsets></italic><offsets xml_i="17436" xml_f="17452" txt_i="12279" txt_f="12295"> = 0.201) group.</offsets></p><p><offsets xml_i="17459" xml_f="17496" txt_i="12296" txt_f="12333">From the blood biochemistry results (</offsets><xref ref-type="table" rid="t3-nmi-4-2011-065"><offsets xml_i="17543" xml_f="17550" txt_i="12333" txt_f="12340">Table 3</offsets></xref><offsets xml_i="17557" xml_f="17730" txt_i="12340" txt_f="12513">), the glucose level of the first test showed no significant difference between groups (control = 79.33 ± 7.99, decaffeinated = 89.10 ± 9.39, caffeine = 84.50 ± 5.83 mg/dL, </offsets><italic><offsets xml_i="17738" xml_f="17739" txt_i="12513" txt_f="12514">P</offsets></italic><offsets xml_i="17748" xml_f="17942" txt_i="12514" txt_f="12708"> = 0.073 from one-way ANOVA test), whereas a significant difference existed in the second test between groups (control = 76.66 ± 7.33, decaffeinated = 88.00 ± 7.33, and caffeine = 88.30 ± 4.87, </offsets><italic><offsets xml_i="17950" xml_f="17951" txt_i="12708" txt_f="12709">P</offsets></italic><offsets xml_i="17960" xml_f="18145" txt_i="12709" txt_f="12894"> = 0.003 from one-way ANOVA test). When comparing between the first and second tests in each group, results showed that the glucose level increased significantly in the caffeine group (</offsets><italic><offsets xml_i="18153" xml_f="18154" txt_i="12894" txt_f="12895">P</offsets></italic><offsets xml_i="18163" xml_f="18208" txt_i="12895" txt_f="12940"> = 0.033), but no difference in the control (</offsets><italic><offsets xml_i="18216" xml_f="18217" txt_i="12940" txt_f="12941">P</offsets></italic><offsets xml_i="18226" xml_f="18254" txt_i="12941" txt_f="12969"> = 0.225) or decaffeinated (</offsets><italic><offsets xml_i="18262" xml_f="18263" txt_i="12969" txt_f="12970">P</offsets></italic><offsets xml_i="18272" xml_f="18319" txt_i="12970" txt_f="13017"> = 0.540) group according to the paired t-test.</offsets></p><p><offsets xml_i="18326" xml_f="18503" txt_i="13018" txt_f="13195">Total antioxidant capacity (TAC) showed no significant difference in either the first (control = 0.84 ± 0.59, decaffeinated = 0.98 ± 0.14, caffeine = 1.00 ± 0.22 mmol Trolox/L, </offsets><italic><offsets xml_i="18511" xml_f="18512" txt_i="13195" txt_f="13196">P</offsets></italic><offsets xml_i="18521" xml_f="18633" txt_i="13196" txt_f="13308"> = 0.199) or second test (control = 0.80 ± 0.05, decaffeinated =1.05±0.24,and caffeine=0.99±0.22 mmol Trolox/L, </offsets><italic><offsets xml_i="18641" xml_f="18642" txt_i="13308" txt_f="13309">P</offsets></italic><offsets xml_i="18651" xml_f="18763" txt_i="13309" txt_f="13421"> =0.100).When comparing between the first and second test in each group, there was no statistical difference (p </offsets><sub><offsets xml_i="18768" xml_f="18775" txt_i="13421" txt_f="13428">control</offsets></sub><offsets xml_i="18781" xml_f="18793" txt_i="13428" txt_f="13440"> = 0.140, p </offsets><sub><offsets xml_i="18798" xml_f="18808" txt_i="13440" txt_f="13450">decaffeine</offsets></sub><offsets xml_i="18814" xml_f="18826" txt_i="13450" txt_f="13462"> = 0.153, p </offsets><sub><offsets xml_i="18831" xml_f="18839" txt_i="13462" txt_f="13470">caffeine</offsets></sub><offsets xml_i="18845" xml_f="18855" txt_i="13470" txt_f="13480"> = 0.759).</offsets></p><p><offsets xml_i="18862" xml_f="19056" txt_i="13481" txt_f="13675">In lipid peroxide (Malondialdehyde), there was no statistical difference in the first test between groups (control = 5.64 ± 2.04, decaffeinated = 8.86 ± 3.91, and caffeine = 6.87 ± 1.86 μmol/L, </offsets><italic><offsets xml_i="19064" xml_f="19065" txt_i="13675" txt_f="13676">P</offsets></italic><offsets xml_i="19074" xml_f="19256" txt_i="13676" txt_f="13858"> = 0.259), but the MDA levels in the second test were significantly different between groups (control = 5.11 ± 1.86, decaffeinated = 6.34 ± 1.86, and caffeine = 11.77 ± 8.45 μmol/L, </offsets><italic><offsets xml_i="19264" xml_f="19265" txt_i="13858" txt_f="13859">P</offsets></italic><offsets xml_i="19274" xml_f="19391" txt_i="13859" txt_f="13976"> = 0.042). The LSD statistical tool showed a higher level of MDA in the caffeine group when compared to the control (</offsets><italic><offsets xml_i="19399" xml_f="19400" txt_i="13976" txt_f="13977">P</offsets></italic><offsets xml_i="19409" xml_f="19444" txt_i="13977" txt_f="14012"> = 0.028) and decaffeinated group (</offsets><italic><offsets xml_i="19452" xml_f="19453" txt_i="14012" txt_f="14013">P</offsets></italic><offsets xml_i="19462" xml_f="19622" txt_i="14013" txt_f="14173"> = 0.037). When comparing the statistical difference between before and after exercise in each groups, the result showed a higher level of MDA in the caffeine (</offsets><italic><offsets xml_i="19630" xml_f="19631" txt_i="14173" txt_f="14174">P</offsets></italic><offsets xml_i="19640" xml_f="19731" txt_i="14174" txt_f="14265"> = 0.005) group, but the control and decaffeinated group showed no statistical difference (</offsets><italic><offsets xml_i="19739" xml_f="19740" txt_i="14265" txt_f="14266">P</offsets></italic><offsets xml_i="19749" xml_f="19762" txt_i="14266" txt_f="14279"> = 0.500 and </offsets><italic><offsets xml_i="19770" xml_f="19771" txt_i="14279" txt_f="14280">P</offsets></italic><offsets xml_i="19780" xml_f="19790" txt_i="14280" txt_f="14290"> = 0.074).</offsets></p><p><offsets xml_i="19797" xml_f="19957" txt_i="14291" txt_f="14451">Finally, the results of blood caffeine in the first test showed no statistical difference between groups (control = 2.83 ± 6.9, 6.10 ± 10.07, 5.9 ± 5.44 mg/mL, </offsets><italic><offsets xml_i="19965" xml_f="19966" txt_i="14451" txt_f="14452">P</offsets></italic><offsets xml_i="19975" xml_f="20145" txt_i="14452" txt_f="14622"> = 0.691), but the caffeine group showed a significantly higher level (18.7 ± 9.6 mg/mL) than the control (0.00 ± 0.00 mg/mL) and decaffeinated (1.3 ± 4.11 mg/mL) group (</offsets><italic><offsets xml_i="20153" xml_f="20154" txt_i="14622" txt_f="14623">P</offsets></italic><offsets xml_i="20163" xml_f="20295" txt_i="14623" txt_f="14755"> = 0.000) in the second test. When comparing between the first and second tests within groups, the control group showed no changes (</offsets><italic><offsets xml_i="20303" xml_f="20304" txt_i="14755" txt_f="14756">P</offsets></italic><offsets xml_i="20313" xml_f="20355" txt_i="14756" txt_f="14798"> = 0.317), as in the decaffeinated group (</offsets><italic><offsets xml_i="20363" xml_f="20364" txt_i="14798" txt_f="14799">P</offsets></italic><offsets xml_i="20373" xml_f="20447" txt_i="14799" txt_f="14873"> = 0.066), but the caffeine group showed a significantly increased level (</offsets><italic><offsets xml_i="20455" xml_f="20456" txt_i="14873" txt_f="14874">P</offsets></italic><offsets xml_i="20465" xml_f="20475" txt_i="14874" txt_f="14884"> = 0.008).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="20519" xml_f="20529" txt_i="14886" txt_f="14896">Discussion</offsets></title><p><offsets xml_i="20540" xml_f="20658" txt_i="14897" txt_f="15015">There have been two studies of caffeine supplementation at 5 mg/mL in healthy men that was tested by the Wingate test,</offsets><xref ref-type="bibr" rid="b19-nmi-4-2011-065"><offsets xml_i="20705" xml_f="20707" txt_i="15015" txt_f="15017">19</offsets></xref><offsets xml_i="20714" xml_f="20715" txt_i="15017" txt_f="15018">–</offsets><xref ref-type="bibr" rid="b21-nmi-4-2011-065"><offsets xml_i="20762" xml_f="20764" txt_i="15018" txt_f="15020">21</offsets></xref><offsets xml_i="20771" xml_f="20901" txt_i="15020" txt_f="15150"> and results showed no effect on physical performance. However, a report by Glaister showed a significant increase in sprint time.</offsets><xref ref-type="bibr" rid="b22-nmi-4-2011-065"><offsets xml_i="20948" xml_f="20950" txt_i="15150" txt_f="15152">22</offsets></xref><offsets xml_i="20957" xml_f="21055" txt_i="15152" txt_f="15250"> Whereas, some studies of athletes showed a significant improvement in power output and endurance,</offsets><xref ref-type="bibr" rid="b23-nmi-4-2011-065"><offsets xml_i="21102" xml_f="21104" txt_i="15250" txt_f="15252">23</offsets></xref><offsets xml_i="21111" xml_f="21387" txt_i="15252" txt_f="15528"> after supplementation. No reports showed a consistency of results, especially in healthy or non-athletic men. Furthermore, no evidence of part oxygen utilization or respiratory exchange ratio (RER) was shown from short term caffeine supplementation at 5 mg/kg of body weight.</offsets></p><p><offsets xml_i="21394" xml_f="21692" txt_i="15529" txt_f="15827">Previous evidence reported that a source of energy utilization is changed after caffeine supplementation from alternating carbohydrate to lipid by increasing plasma free fatty acid (FFA), muscle uptake, and then fat oxidation, which leads to intramuscular glycogen spared through the Randle effect.</offsets><xref ref-type="bibr" rid="b4-nmi-4-2011-065"><offsets xml_i="21738" xml_f="21739" txt_i="15827" txt_f="15828">4</offsets></xref><offsets xml_i="21746" xml_f="21915" txt_i="15828" txt_f="15997"> Previous evidence showed increases of nonesterified fatty acids and glucose availability on metabolism from moderate or intense dynamic exercise for at least 15–60 min.</offsets><xref ref-type="bibr" rid="b24-nmi-4-2011-065"><offsets xml_i="21962" xml_f="21964" txt_i="15997" txt_f="15999">24</offsets></xref><offsets xml_i="21971" xml_f="22445" txt_i="15999" txt_f="16473"> The results from this study showed that the blood glucose level increased significantly in the second test when compared to the first one. In addition, MDA from lipid peroxidation is the most common marker used to present the nonenzymatic oxidation in case of more mono- or polyunsaturated fatty acids in blood circulation. Previous report showed that mobilization of the free fatty acid from adipose tissue was related to the intensity of exercise between 25% to 65% of VO</offsets><sub><offsets xml_i="22450" xml_f="22456" txt_i="16473" txt_f="16479">2 max.</offsets></sub><xref ref-type="bibr" rid="b25-nmi-4-2011-065"><offsets xml_i="22509" xml_f="22511" txt_i="16479" txt_f="16481">25</offsets></xref><offsets xml_i="22518" xml_f="22752" txt_i="16481" txt_f="16715"> The results showed significant increase in MDA in the caffeine group from the first to second test. Thus, these results were similar and confirmed previous evidence. This study was similar to a previous one by Sprient and colleagues,</offsets><xref ref-type="bibr" rid="b26-nmi-4-2011-065"><offsets xml_i="22799" xml_f="22801" txt_i="16715" txt_f="16717">26</offsets></xref><offsets xml_i="22808" xml_f="22967" txt_i="16717" txt_f="16876"> who showed that the supplementation of caffeine at 5 mg/kg of body weight increased significantly in intramuscular fat oxidation during leg ergometer cycling.</offsets></p><p><offsets xml_i="22974" xml_f="23056" txt_i="16877" txt_f="16959">Physical performance and source of energy utilization were studied by measuring VO</offsets><sub><offsets xml_i="23061" xml_f="23062" txt_i="16959" txt_f="16960">2</offsets></sub><offsets xml_i="23068" xml_f="23217" txt_i="16960" txt_f="17109"> and RER. The respiratory exchange ratio (RER) is a common parameter for energy source during exercise, as it can be calculated from the ratio of VCO</offsets><sub><offsets xml_i="23222" xml_f="23223" txt_i="17109" txt_f="17110">2</offsets></sub><offsets xml_i="23229" xml_f="23236" txt_i="17110" txt_f="17117"> and VO</offsets><sub><offsets xml_i="23241" xml_f="23242" txt_i="17117" txt_f="17118">2</offsets></sub><offsets xml_i="23248" xml_f="23761" txt_i="17118" txt_f="17631"> and breath-by-breath analysis. A ratio of more than 1.0 indicates anaerobic metabolism, and a normal RER ratio should be in the range of 0.82–0.85. Source utilization for exercise is delivered from carbohydrate, fat, or protein, and the presents with a RER ratio such as 1.0 (100% carbohydrate), 0.7 (% 100 fat), and 0.8 (100% protein), therefore shifting the RER at less than 1.0 represents the fat or protein was more metabolized as well as carbohydrate. This study showed similar results of changes in both VO</offsets><sub><offsets xml_i="23766" xml_f="23767" txt_i="17631" txt_f="17632">2</offsets></sub><offsets xml_i="23773" xml_f="23835" txt_i="17632" txt_f="17694"> and RER in the caffeine group by a significant increase of VO</offsets><sub><offsets xml_i="23840" xml_f="23841" txt_i="17694" txt_f="17695">2</offsets></sub><offsets xml_i="23847" xml_f="24198" txt_i="17695" txt_f="18046"> level between the first and second test and significantly reduced RER from the first to second test, whereas, no significant difference was shown in the control and decaffeinated group. This result was similar to that in a previous study which researched 10 sedentary men by supplementing coffee with 3 g of caffeine, and results showed increasing VO</offsets><sub><offsets xml_i="24203" xml_f="24204" txt_i="18046" txt_f="18047">2</offsets></sub><offsets xml_i="24210" xml_f="24277" txt_i="18047" txt_f="18114"> values of high-intensity effort from a 1,500 meter treadmill test.</offsets><xref ref-type="bibr" rid="b27-nmi-4-2011-065"><offsets xml_i="24324" xml_f="24326" txt_i="18114" txt_f="18116">27</offsets></xref><offsets xml_i="24333" xml_f="24541" txt_i="18116" txt_f="18324"> Although this study did not determine the running time to exhaustion, a previous one showed that caffeine supplementation at 5 mg/mL increased the running time to exhaustion compared to runners on a placebo.</offsets><xref ref-type="bibr" rid="b8-nmi-4-2011-065"><offsets xml_i="24587" xml_f="24588" txt_i="18324" txt_f="18325">8</offsets></xref><offsets xml_i="24595" xml_f="24858" txt_i="18325" txt_f="18588"> In the study of Grossman, caffeine supplementation increased exercise time to exhaustion regardless of whether it was in a hydrous or anhydrous form, and in the range of 3–7 mg/kg of body weight it provided an average increase in performance of 24% over placebo.</offsets><xref ref-type="bibr" rid="b28-nmi-4-2011-065"><offsets xml_i="24905" xml_f="24907" txt_i="18588" txt_f="18590">28</offsets></xref><offsets xml_i="24914" xml_f="24977" txt_i="18590" txt_f="18653"> In addition, caffeine is claimed to be an antioxidant compound</offsets><xref ref-type="bibr" rid="b12-nmi-4-2011-065"><offsets xml_i="25024" xml_f="25026" txt_i="18653" txt_f="18655">12</offsets></xref><offsets xml_i="25033" xml_f="25286" txt_i="18655" txt_f="18908"> that scavenges free radicals and oxidation on lipid membranes in vitro. This study evaluated the total antioxidant capacity in blood before and after the submaximal exercise test. The results showed a non-significant difference within the three groups.</offsets></p><p><offsets xml_i="25293" xml_f="25705" txt_i="18909" txt_f="19321">This study rechecked the level of caffeine in all groups and results confirmed that caffeine supplementation increased the caffeine level when compared to the control and decaffeinated group. Previous to this study period, blood caffeine in all groups could be detected from regular daily supplement, as there are many plants, vegetables and some beverages like tea and milk chocolate that also contain caffeine.</offsets><xref ref-type="bibr" rid="b2-nmi-4-2011-065"><offsets xml_i="25751" xml_f="25752" txt_i="19321" txt_f="19322">2</offsets></xref><offsets xml_i="25759" xml_f="25907" txt_i="19322" txt_f="19470"> However, in the control and decaffeinated group, the caffeine level was reduced or absent after exercise, which was opposite to the caffeine group.</offsets></p><p><offsets xml_i="25914" xml_f="26212" txt_i="19471" txt_f="19769">Many studies have explained the mechanisms of caffeine in physical performance, such as activation of calcium release from the sarcoplasmic reticulum and effects on muscle contraction and across the membranes of nerves and muscle cells that have more powerful effects on steps other than metabolism</offsets><xref ref-type="bibr" rid="b29-nmi-4-2011-065"><offsets xml_i="26259" xml_f="26261" txt_i="19769" txt_f="19771">29</offsets></xref><offsets xml_i="26268" xml_f="26323" txt_i="19771" txt_f="19826"> and also primary action on the central nervous system.</offsets><xref ref-type="bibr" rid="b30-nmi-4-2011-065"><offsets xml_i="26370" xml_f="26372" txt_i="19826" txt_f="19828">30</offsets></xref><offsets xml_i="26379" xml_f="26573" txt_i="19828" txt_f="20022"> In order to improve endurance performance, another possible caffeine mechanism is releasing beta-endorphin after caffeine supplement at 6 mg/kg of body weight during two hours cycling at 65% VO</offsets><sub><offsets xml_i="26578" xml_f="26579" txt_i="20022" txt_f="20023">2</offsets></sub><offsets xml_i="26585" xml_f="26590" txt_i="20023" txt_f="20028"> max.</offsets><xref ref-type="bibr" rid="b7-nmi-4-2011-065"><offsets xml_i="26636" xml_f="26637" txt_i="20028" txt_f="20029">7</offsets></xref><offsets xml_i="26644" xml_f="26965" txt_i="20029" txt_f="20350"> Current evidence suggests that the combined supplement between caffeine and creatine will improve physical performance better than caffeine on its own. For example, the study of Lee and coworker (2011) showed the significant benefit of creatine loading before caffeine supplementation in a peak power test on a sprinter.</offsets><xref ref-type="bibr" rid="b31-nmi-4-2011-065"><offsets xml_i="27012" xml_f="27014" txt_i="20350" txt_f="20352">31</offsets></xref></p></sec><sec><title><offsets xml_i="27043" xml_f="27053" txt_i="20354" txt_f="20364">Conclusion</offsets></title><p><offsets xml_i="27064" xml_f="27263" txt_i="20365" txt_f="20564">It can be concluded that a moderate dose of caffeine is a well described ergogenic aid in various commercial products, as coffee powder shows enhancing effects on physical performance by increased VO</offsets><sub><offsets xml_i="27268" xml_f="27269" txt_i="20564" txt_f="20565">2</offsets></sub><offsets xml_i="27275" xml_f="27707" txt_i="20565" txt_f="20997"> consumption and altered source of energy by releasing glucose and lipid oxidation in blood circulation. Although this study was performed in a small group of sedentary men, we found some interesting in practical useful on supplement or nutrition for improve exercise capacity or physical performance in sedentary subjects. But it also needs more confirmation on the dose and type of exercise that may have influence on the results.</offsets></p></sec></body><back><fn-group><fn><p><bold>Authors’ Contributions</bold></p><p>LD was responsible for the study designs, overseeing data collection, biochemical work, statistical analysis, and preparation of the manuscript. MS was responsible for data collection/and assistance with laboratory work, and SC was rechecked and all data.</p></fn><fn><p><bold>Disclosures</bold></p><p>Author(s) have provided signed confirmations to the publisher of their compliance with all applicable legal and ethical obligations in respect to declaration of conflicts of interest, funding, authorship and contributorship, and compliance with ethical requirements in respect to treatment of human and animal test subjects. If this article contains identifiable human subject(s) author(s) were required to supply signed patient consent prior to publication. Author(s) have confirmed that the published article is unique and not under consideration nor published by any other publication and that they have consent to reproduce any copyrighted material. The peer reviewers declared no conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-nmi-4-2011-065"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name></person-group><article-title>Caffeine and Creatine Use in sport</article-title><source>Ann Nutr Metab</source><year>2010</year><volume>57</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21346331</pub-id></element-citation></ref><ref id="b2-nmi-4-2011-065"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>HG</given-names></name></person-group><article-title>Update on caffeine consumption, disposition, and action</article-title><source>Food Chem Toxicol</source><year>2002</year><volume>40</volume><fpage>1231</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12204386</pub-id></element-citation></ref><ref id="b3-nmi-4-2011-065"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name></person-group><article-title>Caffeine and endurance performance</article-title><source>Sport Med</source><year>1994</year><volume>18</volume><fpage>109</fpage><lpage>25</lpage></element-citation></ref><ref id="b4-nmi-4-2011-065"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costill</surname><given-names>DL</given-names></name><name><surname>Dalsky</surname><given-names>GP</given-names></name><name><surname>Fink</surname><given-names>WJ</given-names></name></person-group><article-title>Effects of caffeine ingestion on metabolism and exercise performance</article-title><source>Med Sci Sports</source><year>1978</year><volume>10</volume><fpage>155</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">723503</pub-id></element-citation></ref><ref id="b5-nmi-4-2011-065"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maughan</surname><given-names>RJ</given-names></name></person-group><article-title>Nutritional ergoneic aids and exercise performance</article-title><source>Nutr Research Reviews</source><year>1999</year><volume>12</volume><fpage>255</fpage><lpage>80</lpage></element-citation></ref><ref id="b6-nmi-4-2011-065"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name></person-group><article-title>Effect of caffeine on the neuromuscular system-potential as an ergogenic aid</article-title><source>Appl Physiol Nutr Metab</source><year>2008</year><volume>33</volume><fpage>1284</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19088790</pub-id></element-citation></ref><ref id="b7-nmi-4-2011-065"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname><given-names>D</given-names></name><name><surname>Schneider</surname><given-names>KE</given-names></name><name><surname>Prusaczyk</surname><given-names>WK</given-names></name><etal></etal></person-group><article-title>Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise</article-title><source>J Clin Endocrinal Metab</source><year>2000</year><volume>85</volume><fpage>2170</fpage><lpage>5</lpage></element-citation></ref><ref id="b8-nmi-4-2011-065"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ping</surname><given-names>WC</given-names></name><name><surname>Keong</surname><given-names>CC</given-names></name><name><surname>Bandyopadhyay</surname><given-names>A</given-names></name></person-group><article-title>Effect of acute supplementation of caffeine on cardiorespiratory responses during endurance running in a hot and humid climate</article-title><source>Indian J Med Res</source><year>2010</year><volume>132</volume><fpage>36</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">20693587</pub-id></element-citation></ref><ref id="b9-nmi-4-2011-065"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>FSC</given-names></name><name><surname>Costa</surname><given-names>NMB</given-names></name><name><surname>Ferreira</surname><given-names>SA</given-names></name><etal></etal></person-group><article-title>The effects of a high dosage of creatine and caffeine supplementation on the lean body mass composition of rats submitted to vertical jumping training</article-title><source>J Int Soc Sports Nutr</source><year>2011</year><volume>8</volume><fpage>3</fpage><pub-id pub-id-type="pmid">21362194</pub-id></element-citation></ref><ref id="b10-nmi-4-2011-065"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>ER</given-names></name><name><surname>Ziegenfuss</surname><given-names>T</given-names></name><name><surname>Kalman</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>J International society of sports nutrition position stand: caffeine and performance</article-title><source>J Int Soc Sports Nutr</source><year>2010</year><volume>7</volume><fpage>5</fpage><pub-id pub-id-type="pmid">20205813</pub-id></element-citation></ref><ref id="b11-nmi-4-2011-065"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name></person-group><article-title>Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation</article-title><source>Clin Chim Acta</source><year>2000</year><volume>295</volume><fpage>141</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">10767400</pub-id></element-citation></ref><ref id="b12-nmi-4-2011-065"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gómez-Ruiz</surname><given-names>JA</given-names></name><name><surname>Leake</surname><given-names>DS</given-names></name><name><surname>Ames</surname><given-names>JM</given-names></name></person-group><article-title>In vitro antioxidant activity of coffee compounds and their metabolites</article-title><source>J Agric Food Chem</source><year>2007</year><volume>55</volume><fpage>6962</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17655324</pub-id></element-citation></ref><ref id="b13-nmi-4-2011-065"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kot</surname><given-names>M</given-names></name><name><surname>Daniel</surname><given-names>WA</given-names></name></person-group><article-title>Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat</article-title><source>Pharmacol Rep</source><year>2008</year><volume>60</volume><fpage>789</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">19211970</pub-id></element-citation></ref><ref id="b14-nmi-4-2011-065"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American College of Sport Medicine (ACSM)</collab></person-group><source>ACSM’s guidelines for exercise testing and prescription</source><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>Lippincott Williams &amp; Wilkins</publisher-name><year>2004</year></element-citation></ref><ref id="b15-nmi-4-2011-065"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leelarungrayub</surname><given-names>D</given-names></name><name><surname>Pratanaphon</surname><given-names>S</given-names></name><name><surname>Pothongsunun</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate; relation to oxidative stress status and beta-endorphin release in active smokers</article-title><source>J Int Soc Sports Nutr.</source><year>2010</year><volume>26</volume><comment>7</comment><fpage>21</fpage><pub-id pub-id-type="pmid">20500899</pub-id></element-citation></ref><ref id="b16-nmi-4-2011-065"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>R</given-names></name><name><surname>Pellegrini</surname><given-names>N</given-names></name><name><surname>Proteggente</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Antioxidant activity applying an improved ABTS radical cation decolorization assay</article-title><source>Free Radic Biol Med</source><year>1999</year><volume>26</volume><fpage>1231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10381194</pub-id></element-citation></ref><ref id="b17-nmi-4-2011-065"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>MJ</given-names></name><name><surname>Pablos</surname><given-names>F</given-names></name><name><surname>Gonzalez</surname><given-names>AG</given-names></name></person-group><article-title>Simutaneous determination of caffeine and non-steroidal anti-inflammatory drugs in pharmaceutical formulations and blood plasma by reversed-phase HPLC form linear gradient elution</article-title><source>Talanta</source><year>1999</year><volume>49</volume><fpage>453</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18967618</pub-id></element-citation></ref><ref id="b18-nmi-4-2011-065"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamimori</surname><given-names>GH</given-names></name><name><surname>Karyekar</surname><given-names>CS</given-names></name><name><surname>Otterstetter</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>The rate of absorption and relative bioavailability of caffeine administrated in chewing gum versus capsules to normal healthy volunteers</article-title><source>Int J Pharm</source><year>2002</year><volume>234</volume><fpage>159</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11839447</pub-id></element-citation></ref><ref id="b19-nmi-4-2011-065"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astorina</surname><given-names>TA</given-names></name><name><surname>Roberson</surname><given-names>DW</given-names></name></person-group><article-title>Efficay of acute caffeine ingestion for short-term high-intensity exercise performance: A systematic review</article-title><source>J Strength Cond Res</source><year>2010</year><volume>24</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">19924012</pub-id></element-citation></ref><ref id="b20-nmi-4-2011-065"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collomp</surname><given-names>K</given-names></name><name><surname>Ahmaid</surname><given-names>S</given-names></name><name><surname>Audran</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Effects of caffeine ingestion on performance and anaerobic metabolism during the Wingate test</article-title><source>Int J Sports Med</source><year>1991</year><volume>12</volume><fpage>439</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">1752708</pub-id></element-citation></ref><ref id="b21-nmi-4-2011-065"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>F</given-names></name><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Coles</surname><given-names>M</given-names></name></person-group><article-title>Wingate performance and surface EMG frequency variables are not affected by caffeine ingestion</article-title><source>Appl Physiol Nutri Metab</source><year>2006</year><volume>31</volume><fpage>597</fpage><lpage>603</lpage></element-citation></ref><ref id="b22-nmi-4-2011-065"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaister</surname><given-names>M</given-names></name><name><surname>Howatson</surname><given-names>G</given-names></name><name><surname>Abraham</surname><given-names>CS</given-names></name><etal></etal></person-group><article-title>Caffeine supplementation and multiple sprint running performance</article-title><source>Med Sci Sports Exer</source><year>2008</year><volume>40</volume><fpage>1835</fpage><lpage>40</lpage></element-citation></ref><ref id="b23-nmi-4-2011-065"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiles</surname><given-names>JD</given-names></name><name><surname>Coleman</surname><given-names>D</given-names></name><name><surname>Tegerdine</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>The effects of caffeine ingestion on performance time, speed, and power during a laboratory-based 1 km cycling time-trial</article-title><source>J Sports Sci</source><year>2006</year><volume>24</volume><fpage>1165</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17035165</pub-id></element-citation></ref><ref id="b24-nmi-4-2011-065"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname><given-names>JA</given-names></name></person-group><article-title>Effect of increased fat availability on metabolism and exercise capacity</article-title><source>Med Sci Sports Exercise</source><year>2002</year><fpage>1485</fpage><lpage>91</lpage></element-citation></ref><ref id="b25-nmi-4-2011-065"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arner</surname><given-names>P</given-names></name><name><surname>Kriegholm</surname><given-names>E</given-names></name><name><surname>Engfeldt</surname><given-names>P</given-names></name><name><surname>Bolinder</surname><given-names>J</given-names></name></person-group><article-title>Adrenergic regulation of lipolysis in situ at rest and during exercise</article-title><source>J Clin Invest</source><year>1990</year><volume>85</volume><fpage>893</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2312732</pub-id></element-citation></ref><ref id="b26-nmi-4-2011-065"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spriet</surname><given-names>LL</given-names></name><name><surname>MacLean</surname><given-names>DA</given-names></name><name><surname>Dyck</surname><given-names>DJ</given-names></name><etal></etal></person-group><article-title>Caffeine ingestion and muscle metabolism during prolonged exercise in humans</article-title><source>Am J Physiol</source><year>1992</year><volume>262</volume><fpage>E891</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1616022</pub-id></element-citation></ref><ref id="b27-nmi-4-2011-065"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>A</given-names></name><name><surname>Sutton</surname><given-names>JR</given-names></name></person-group><article-title>Endorphins: What are they? How are they measured? What is their role in exercise?</article-title><source>Med Sci Sports Exerc</source><year>1985</year><volume>17</volume><fpage>74</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">2858810</pub-id></element-citation></ref><ref id="b28-nmi-4-2011-065"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demura</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Terasawa</surname><given-names>N</given-names></name></person-group><article-title>Effect of coffee ingestion on physiological responses and ratings of perceived exertion during submaximal endurance exercise</article-title><source>Percept Mot Skills</source><year>2007</year><volume>105</volume><fpage>1109</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">18380106</pub-id></element-citation></ref><ref id="b29-nmi-4-2011-065"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spriet</surname><given-names>LL</given-names></name></person-group><article-title>Caffeine and performance</article-title><source>Int J of Sport Nutr</source><year>1995</year><volume>5</volume><fpage>S84</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">7550260</pub-id></element-citation></ref><ref id="b30-nmi-4-2011-065"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fredholm</surname><given-names>BB</given-names></name><name><surname>Holmen</surname><given-names>J</given-names></name><name><surname>Nehlig</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Actions of caffeine in the brain with special reference to factors that contribute to its widespread use</article-title><source>Pharmacol Rev</source><year>1999</year><volume>51</volume><fpage>83</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">10049999</pub-id></element-citation></ref><ref id="b31-nmi-4-2011-065"><label>31.</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CL</given-names></name><name><surname>Lin</surname><given-names>JC</given-names></name><name><surname>Cheng</surname><given-names>CF</given-names></name></person-group><article-title>Effect of caffeine ingestion after creatine supplementation on intermittent high-intensity sprint performance</article-title><source>Eur J Appl Physiol</source><year>2011</year><fpage>xx</fpage><comment>(In press).</comment></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-nmi-4-2011-065" position="float"><label>Table 1</label><caption><p>Characteristics of sedentary men in the control, decaffeinated and caffeine group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"></th><th align="left" valign="middle" rowspan="1" colspan="1">Control (n = 6)</th><th align="left" valign="middle" rowspan="1" colspan="1">Decaffeinated (n = 10)</th><th align="left" valign="middle" rowspan="1" colspan="1">Caffeine (n = 10)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Aged (years)</td><td align="left" valign="top" rowspan="1" colspan="1">20.17 ± 0.98 (19–21)</td><td align="left" valign="top" rowspan="1" colspan="1">20.3 ± 0.48 (20–21)</td><td align="left" valign="top" rowspan="1" colspan="1">20.5 ± 0.53 (20–21)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="left" valign="top" rowspan="1" colspan="1">67.08 ± 10.70 (52–80)</td><td align="left" valign="top" rowspan="1" colspan="1">64.75 ± 12.13 (50–83)</td><td align="left" valign="top" rowspan="1" colspan="1">62.94 ± 10.38 (50–81)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height (m)</td><td align="left" valign="top" rowspan="1" colspan="1">1.75 ± 0.03 (1.67–1.77)</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 ± 0.06 (1.60–1.80)</td><td align="left" valign="top" rowspan="1" colspan="1">1.73 ± 0.05 (1.68–1.85)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg · m<sup>−2</sup>)</td><td align="left" valign="top" rowspan="1" colspan="1">23.06 ± 3.60 (18.64–28.03)</td><td align="left" valign="top" rowspan="1" colspan="1">22.27 ± 3.56 (17.92–29.76)</td><td align="left" valign="top" rowspan="1" colspan="1">22.84 ± 2.65 (17.71–28.75)</td></tr></tbody></table></table-wrap><table-wrap id="t2-nmi-4-2011-065" position="float"><label>Table 2</label><caption><p>Energy utilization; VO<sub>2</sub> and RER among the control, decaffeinated and caffeine group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="3" colspan="1"></th><th colspan="2" align="left" valign="middle" rowspan="1">Control (n = 6)</th><th colspan="2" align="left" valign="middle" rowspan="1">Decaffeinated (n = 10)</th><th colspan="2" align="left" valign="middle" rowspan="1">Caffeine (n = 10)</th></tr><tr><th colspan="2" align="left" valign="middle" rowspan="1">
<hr></hr></th><th colspan="2" align="center" valign="middle" rowspan="1">
<hr></hr></th><th colspan="2" align="center" valign="middle" rowspan="1">
<hr></hr></th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">first test</th><th align="left" valign="middle" rowspan="1" colspan="1">second test</th><th align="left" valign="middle" rowspan="1" colspan="1">first test</th><th align="center" valign="middle" rowspan="1" colspan="1">second test</th><th align="left" valign="middle" rowspan="1" colspan="1">first test</th><th align="left" valign="middle" rowspan="1" colspan="1">second test</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> (mL/kg/min)</td><td align="left" valign="top" rowspan="1" colspan="1">27.3 ± 1.89 (29.28–25.50)</td><td align="left" valign="top" rowspan="1" colspan="1">29.68 ± 3.90 (33.77–24.34)</td><td align="left" valign="top" rowspan="1" colspan="1">32.52 ± 5.19<xref ref-type="table-fn" rid="tfn2-nmi-4-2011-065"><sup>a</sup></xref> (36.24–23.06)</td><td align="left" valign="top" rowspan="1" colspan="1">34.51 ± 6.34 (38.04–25.26)</td><td align="left" valign="top" rowspan="1" colspan="1">28.07 ± 4.45 (31.25–17.90)</td><td align="left" valign="top" rowspan="1" colspan="1">32.41 ± 5.17<xref ref-type="table-fn" rid="tfn4-nmi-4-2011-065"><sup>c</sup></xref> (36.11–24.56)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RER</td><td align="left" valign="top" rowspan="1" colspan="1">1.09 ± 0.07 (1.05–1.24)</td><td align="left" valign="top" rowspan="1" colspan="1">1.03 ± 0.06 (0.93–1.11)</td><td align="left" valign="top" rowspan="1" colspan="1">1.07 ± 0.10 (0.95–1.25)</td><td align="left" valign="top" rowspan="1" colspan="1">1.02 ± 0.05 (0.96–1.13)</td><td align="left" valign="top" rowspan="1" colspan="1">1.06 ± 0.08 (0.91–1.18)</td><td align="left" valign="top" rowspan="1" colspan="1">0.99 ± 0.06c (0.86–1.13)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-nmi-4-2011-065"><p><bold>Notes:</bold></p></fn><fn id="tfn2-nmi-4-2011-065"><label>a</label><p><italic>P</italic> &lt; 0.05, compared to other groups at pre-drinking with an LSD in the one-way ANOVA test;</p></fn><fn id="tfn3-nmi-4-2011-065"><label>b</label><p><italic>P</italic> &lt; 0.05, compared to other groups at post-drinking with an LSD in the one-way ANOVA test;</p></fn><fn id="tfn4-nmi-4-2011-065"><label>c</label><p><italic>P</italic> &lt; 0.05 (Wilcoxon Signed Ranks Test), compared to the pre-drinking group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-nmi-4-2011-065" position="float"><label>Table 3</label><caption><p>Blood biochemistry parameters; glucose, total antioxidant capacity (TAC), malondialdehyde (MDA), and caffeine among the control, decaffeinated and caffeine group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" rowspan="3" colspan="1"></th><th colspan="2" align="left" valign="middle" rowspan="1">Control (n = 6)</th><th colspan="2" align="left" valign="middle" rowspan="1">Decaffeinated (n = 10)</th><th colspan="2" align="left" valign="middle" rowspan="1">Caffeine (n = 10)</th></tr><tr><th colspan="2" align="left" valign="middle" rowspan="1">
<hr></hr></th><th colspan="2" align="left" valign="middle" rowspan="1">
<hr></hr></th><th colspan="2" align="left" valign="middle" rowspan="1">
<hr></hr></th></tr><tr><th align="left" valign="middle" rowspan="1" colspan="1">Before</th><th align="left" valign="middle" rowspan="1" colspan="1">After</th><th align="left" valign="middle" rowspan="1" colspan="1">Before</th><th align="left" valign="middle" rowspan="1" colspan="1">After</th><th align="left" valign="middle" rowspan="1" colspan="1">Before</th><th align="left" valign="middle" rowspan="1" colspan="1">After</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Glucose (mg/dL)</td><td align="left" valign="top" rowspan="1" colspan="1">79.33 ± 7.99 (66–86)</td><td align="left" valign="top" rowspan="1" colspan="1">76.66 ± 7.33<xref ref-type="table-fn" rid="tfn7-nmi-4-2011-065"><sup>b</sup></xref> (65–85)</td><td align="left" valign="top" rowspan="1" colspan="1">89.10 ± 9.39 (72–102)</td><td align="left" valign="top" rowspan="1" colspan="1">88.00 ± 7.33 (78–98)</td><td align="left" valign="top" rowspan="1" colspan="1">84.50 ± 5.83 (76–92)</td><td align="left" valign="top" rowspan="1" colspan="1">88.30 ± 4.87<xref ref-type="table-fn" rid="tfn8-nmi-4-2011-065"><sup>c</sup></xref> (81–95)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TAC (μmol Trolox/L)</td><td align="left" valign="top" rowspan="1" colspan="1">0.84 ± 0.59 (0.78–0.92)</td><td align="left" valign="top" rowspan="1" colspan="1">0.80 ± 0.05 (0.74–0.89)</td><td align="left" valign="top" rowspan="1" colspan="1">0.98 ± 0.14 (0.75–1.16)</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 ± 0.24 (0.80–1.62)</td><td align="left" valign="top" rowspan="1" colspan="1">1.00 ± 0.22 (0.59–1.27)</td><td align="left" valign="top" rowspan="1" colspan="1">0.99 ± 0.22 (0.54–1.62)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDA (μmol/L)</td><td align="left" valign="top" rowspan="1" colspan="1">5.64 ± 2.04 (2.66–8.85)</td><td align="left" valign="top" rowspan="1" colspan="1">5.11 ± 1.86 (2.89–8.09)</td><td align="left" valign="top" rowspan="1" colspan="1">8.86 ± 3.91 (3.55–14.66)</td><td align="left" valign="top" rowspan="1" colspan="1">6.34 ± 1.86 (3.55–9.70)</td><td align="left" valign="top" rowspan="1" colspan="1">6.87 ± 1.86 (3.22–18.65)</td><td align="left" valign="top" rowspan="1" colspan="1">11.77 ± 8.45<sup><xref ref-type="table-fn" rid="tfn7-nmi-4-2011-065">b</xref>,<xref ref-type="table-fn" rid="tfn8-nmi-4-2011-065">c</xref></sup> (4.20–31.11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caffeine (mg/mL)</td><td align="left" valign="top" rowspan="1" colspan="1">2.83 ± 6.9 (0–17)</td><td align="left" valign="top" rowspan="1" colspan="1">0.00 ± 0.00 (0–0)</td><td align="left" valign="top" rowspan="1" colspan="1">6.10 ± 10.07 (0–27)</td><td align="left" valign="top" rowspan="1" colspan="1">1.3 ± 4.11<xref ref-type="table-fn" rid="tfn8-nmi-4-2011-065"><sup>c</sup></xref> (0–13)</td><td align="left" valign="top" rowspan="1" colspan="1">5.9 ± 5.44 (1–17)</td><td align="left" valign="top" rowspan="1" colspan="1">18.7 ± 9.6<sup><xref ref-type="table-fn" rid="tfn7-nmi-4-2011-065">b</xref>, <xref ref-type="table-fn" rid="tfn8-nmi-4-2011-065">c</xref></sup> (1–36)</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-nmi-4-2011-065"><p><bold>Notes:</bold></p></fn><fn id="tfn6-nmi-4-2011-065"><label>a</label><p><italic>P</italic> &lt; 0.05, compared to other groups at pre-drinking with an LSD in the one-way ANOVA test;</p></fn><fn id="tfn7-nmi-4-2011-065"><label>b</label><p><italic>P</italic> &lt; 0.05, compared to other groups at post-drinking with an LSD in the one-way ANOVA test;</p></fn><fn id="tfn8-nmi-4-2011-065"><label>c</label><p><italic>P</italic> &lt; 0.05, (Wilcoxon Signed Ranks Test), compared to the pre-drinking group.</p></fn></table-wrap-foot></table-wrap></floats-group></article>